tiprankstipranks
Vor Biopharma, Inc. (VOR)
NASDAQ:VOR
US Market
VOR
Vor Biopharma
RESEARCH TOOLSreports
Want to see VOR full AI Analyst Report?

Vor Biopharma (VOR) Stock News & Sentiment

960 Followers
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
Premium
Ratings
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
4d ago
VOR
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
Premium
Company Announcements
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
14d ago
VOR
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
Premium
Weekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
27d ago
HDB
STT
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
Premium
Weekend Updates
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
1M ago
BJ
ASO
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
Premium
Weekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
1M ago
SG
VOR
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
Premium
Ratings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
2M ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
Premium
Ratings
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
2M ago
VOR
More VOR News >

VOR News on the Web

Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
TipRanks News
Bullish
Vor Bio price target raised to $18 from $15 at Wedbush
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Halozyme (HALO) and Vor Biopharma (VOR)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Protara Therapeutics (TARA), Vor Biopharma (VOR)
TipRanks News
Neutral
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
TipRanks News
Bullish
Vor Bio files to sell 5.34M shares of common stock for holders
TipRanks News
Neutral
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
TipRanks News
Bearish
Major Vor Biopharma Insider Makes a Multi-Million Dollar Move
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
VOR
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VOR’s Media Buzz Sentiment?
1 articles about VOR were published this week. In an average week, 2.75 articles are published.
    What is VOR’s weekly average amount of articles?
    In an average week, 2.75 articles about VOR are published.
      What is VOR’s News Sentiment?
      99% of articles about VOR were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        JUNSJupiter Neurosciences, Inc.
        Showing the stocks with the most bullish news sentiment over the past week